AngioDynamics, Inc. (ANGO) climbed 8.08 percent to $11.97 on Thursday, gaining $0.90, after reporting a narrower quarterly loss and revenue that topped expectations in the first quarter. The company posted a net loss of $10.9 million, or $0.26 per share, compared with a loss of $12.8 million, or $0.31 per share, a year earlier. Revenue rose 12.2 percent to $75.7 million from $67.5 million a year ago. Shares traded between $11.35 and $12.76, compared with a previous close of $11.07 on the Nasdaq. Volume spiked to 1.99 million shares, well above the average of 534,634.
The stock now sits within its 52-week range of $5.83 to $13.50
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.